The ABC subtype is characterized by mutations in MYD88, CARD11, CD79A and CD79B, and constitutive activation of NF-κB signaling, features associated with less favorable clinical outcome [6, 7]. The gene discussed is MYD88; the disease is aneurysmal bone cyst.